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Background
In developed countries, 0.3% to 0.5% of all newborns are
congenitally infected by cytomegalovirus (CMV) with the
risk of sensorineural hearing loss or mental retardation
[1,2]. Few results about congenital CMV infection in
infants born to HIV-infected women have been reported
[3]. Rate of disease progression and central nervous sys-
tem disease was found to be higher in HIV-1-infected
infants who acquire CMV infection in the first 18 months
of life than those infected with HIV-1 alone [4]. We aimed
to estimate the prevalence of neonatal CMV infection in
children born to HIV-infected mothers between 1993 and
2004 enrolled in the ANRS French Perinatal Cohort (EPF).
Materials and methods
EPF is a national prospective multicenter cohort of
mother-to-child HIV transmission. As part of the stand-
ardized follow-up of infants born alive between 1993 and
2004 in EPF sites, a urine sample was obtained within the
ten first days of life. These samples were used to screen for
congenital CMV infection, using rapid culture from 1993
to 2001 and real-time PCR since 2001.
Results
Between 1993 and 2004, 4995 of the 7878 newborns
included in EPF were screened for CMV. The prevalence of
CMV infection was 2.4% (119 positive tests; 95% confi-
dence interval: 2.0–2.8). Thirteen of the 119 CMV infected
newborns were also infected with HIV. The prevalence of
CMV infection was higher in HIV-infected newborns
(10.2%; 95% CI: 4.9-15.5) than in HIV-uninfected new-
borns (2.2%, 95% CI: 1.8-2.6, p<0.01).
Conclusions
The prevalence of congenital CMV infection was high in
children born to HIV- infected mothers and was signifi-
cantly higher in HIV-infected children than HIV-unin-
fected children.
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